ESG

UAB Kvartalas completes its flagship office project but reports €3.5M in losses, calling a critical meeting as a €40.6M bond payment deadline nears.

As cyber threats loom, Rpharmy's SOC 2 Type II audit signals a deep commitment to protecting sensitive patient data and ensuring system reliability.

As leaders gather for the 70th OSUM conference, 'strong mayor' powers, homelessness, and the upcoming election dominate a high-stakes agenda.

ATCC and the Broad Institute unveil engineered lung cancer cells to decode drug resistance, offering new hope for patients and fueling AI-driven discovery.

Atsena Therapeutics gets the green light for the final trial phase of a promising gene therapy, offering the first real hope for patients with X-linked retinoschisis.

The 15-year partnership between Kia and TotalEnergies is renewed, focusing on cutting-edge lubricants and solutions for the growing EV market.

Tenvie Therapeutics begins human trials for TNV108, a drug that targets the root cause of nerve decay, offering a potential disease-modifying breakthrough.

As the fiber market booms, one brand's two-decade success reveals a powerful link between regenerative agriculture, consumer trust, and digestive wellness.

The historic Napa winery opens its 1880s heart, blending rich history with luxury culinary experiences to redefine the modern wine tasting journey.

At Auto China 2026, JETOUR unveils its 'Travel+' strategy, a dual-brand gambit, and a celebrity partnership aimed at redefining automotive ownership.

Argentina's Javier Milei and Israel's Benjamin Netanyahu sign a historic pact, reshaping regional alliances and creating a new pro-Israel bloc in Latin America.

A NASA-inspired startup is using sound to stop fires. With a key regulatory nod and a role in LA's first 3D-printed home, is this the future?

Donor Alliance, UW athletes, and WYDOT are teaming up to encourage organ donation. Learn how a simple checkmark at the DMV can save nearly 100 Wyoming lives.

As universities replace blue light phones with apps and alerts, a dead battery has become a critical safety failure. One company says the fix is power itself.

PeptiDream and Asahi Kasei's novel drug candidate, AK1940, begins Phase 1 trials, aiming for a safer, more targeted approach to treating autoimmune diseases.

A new immersive platform uses advanced simulators to turn state history and landscapes into thrilling, interactive journeys for the nation's anniversary.

A breakthrough drug for pediatric Hunter syndrome, AVLAYAH™, is now accessible via home infusion through an exclusive Orsini and Denali partnership.

Behind a hidden door at a desert festival, Kiss and Sabrina Carpenter built an exclusive speakeasy, rewriting the playbook for brand-celebrity partnerships.

A $300M deal for mobile natural gas highlights a new strategy to power the AI boom as data centers face decade-long waits for grid connections.

With Cigna's backing, Accord's IMULDOSA is set to challenge a blockbuster drug, promising significant savings for patients and the healthcare system.